Mary Woolley

Research Australia has released its 2013 public opinion poll which reveals strong support for funding health and medical research. The findings provide an interesting backdrop for the country’€™s parliamentary elections this year. Research Australia asked respondents their views on what priorities the Federal Government should be focusing on over the next 2 ’€“ 3 years. Three significant health issues ranked high in the results: improving the hospital and healthcare systems, more funding for health and medical research and increasing funding and programs for preventative healthcare. Australians value a wide range of research, from basic research resulting in new discoveries, to...
Dear Research Advocate: Last week, I wrote about the international trade deficit our country faces. This week, I’€™d like to focus on the budget deficit. From 2003 to 2011, Medicare and Medicaid spending grew 74% while our economy only grew 35%. With that kind of differential, no government can balance its budget. We need research to address disabling and costly illnesses, but that won’t be enough in and of itself to bridge the gap. We also need tax and entitlement reform that preserves needed services, squeezes out waste and inefficiency (by the way, that’€™s why we must also fight to protect health economics research, health services research and other research that optimizes health care...
Dear Research Advocate: Last week, I wrote about the international trade deficit our country faces. This week, I’€™d like to focus on the budget deficit. From 2003 to 2011, Medicare and Medicaid spending grew 74% while our economy only grew 35%. With that kind of differential, no government can balance its budget. We need research to address disabling and costly illnesses, but that won’t be enough in and of itself to bridge the gap. We also need tax and entitlement reform that preserves needed services, squeezes out waste and inefficiency (by the way, that’€™s why we must also fight to protect health economics research, health services research and other research that optimizes health care...
Dear Research Advocate: The Commerce Department’€™s report of the U.S. trade deficit narrowing to its lowest level since October 2009 is welcome news, but the devil is in the details. Despite the economic progress, our trade deficit with China is nearly as large as our overall trade deficit. Put that together with the fact that China is rigorously investing in R&D while our nation stifles it, and you can see the handwriting on the wall. U.S. export capabilities will be stymied while China’€™s are bolstered. It’€™s not a recipe for a strong and stable economy going forward. China is not the only nation steadily increasing investment in R&D, taking a page from what used to be the U.S...
Dear Research Advocate: The Commerce Department'€™s report of the U.S. trade deficit narrowing to its lowest level since October 2009 is welcome news, but the devil is in the details. Despite the economic progress, our trade deficit with China is nearly as large as our overall trade deficit. Put that together with the fact that China is rigorously investing in R&D while our nation stifles it, and you can see the handwriting on the wall. U.S. export capabilities will be stymied while China'€™s are bolstered. It'€™s not a recipe for a strong and stable economy going forward. China is not the only nation steadily increasing investment in R&D, taking a page from what used to be the U.S...
Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
LOW PERCENTAGE HEAR ABOUT CLINICAL TRIALS FROM HEALTH CARE PROVIDERS ALEXANDRIA, Va. – July 31, 2013 – Altruism is a strong motivating factor for clinical trial participation in the general population and even more so among several minority groups.A significant percentage of African-Americans (61%), Hispanics (57%) and Asians (50%) say it's very important to participate as a volunteer in a clinical trial to improve the health of others, compared to 47% of non-Hispanic whites, according to a new national public opinion poll commissioned by Research!America. These findings are tempered by the reality that participation remains disturbingly low among all groups. When asked if they or someone...

Pages

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter